New score predicts risk of postoperative liver failure with high accuracy

Surgical removal of parts of the liver remains the only curative approach for patients with liver-specific cancer.

Neuvivo makes bid to enter ALS arena with immunotherapy candidate – Pharmaceutical Technology

NP001 is designed to reestablish the balance of pro- and anti-inflammatory processes. Credits: David Herraez Calzada/Shutterstock.com Neuvivo has submitted a New Drug Application (NDA) for

October 7, 2024

Hospital CEO Died After Surgery, Lawsuit Follows; Doc Sues Over Noncompete

A hospital CEO died after heart surgery, and now her family is suing the University of Chicago Health System for negligence. Surgeons recommended a heart

February 23, 2024

Vertex says about 20 patients have started sickle cell therapy; cuts two rare disease programs

Vertex Pharmaceuticals is picking up momentum in its strategy of branching out beyond cystic fibrosis. About 20 patients have had their cells collected for Casgevy

August 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.